DK1529216T3 - Fremgangsmåde til diagnosticering af dissemineret sklerose - Google Patents

Fremgangsmåde til diagnosticering af dissemineret sklerose

Info

Publication number
DK1529216T3
DK1529216T3 DK03784432T DK03784432T DK1529216T3 DK 1529216 T3 DK1529216 T3 DK 1529216T3 DK 03784432 T DK03784432 T DK 03784432T DK 03784432 T DK03784432 T DK 03784432T DK 1529216 T3 DK1529216 T3 DK 1529216T3
Authority
DK
Denmark
Prior art keywords
procedure
disseminated sclerosis
diagnosing
diagnosing disseminated
sclerosis
Prior art date
Application number
DK03784432T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Mikael Schwarz
Ari Gargir
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Application granted granted Critical
Publication of DK1529216T3 publication Critical patent/DK1529216T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
DK03784432T 2002-08-02 2003-08-04 Fremgangsmåde til diagnosticering af dissemineret sklerose DK1529216T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40091402P 2002-08-02 2002-08-02
US44707603P 2003-02-13 2003-02-13
US46298403P 2003-04-15 2003-04-15
US47323103P 2003-05-23 2003-05-23
PCT/IB2003/003878 WO2004015420A1 (en) 2002-08-02 2003-08-04 Method for diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
DK1529216T3 true DK1529216T3 (da) 2008-02-25

Family

ID=31721743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03784432T DK1529216T3 (da) 2002-08-02 2003-08-04 Fremgangsmåde til diagnosticering af dissemineret sklerose

Country Status (18)

Country Link
US (2) US7537900B2 (da)
EP (1) EP1529216B1 (da)
JP (2) JP4721703B2 (da)
AT (1) ATE376672T1 (da)
AU (1) AU2003263409B2 (da)
BR (1) BR0313194A (da)
CA (1) CA2494422A1 (da)
CY (1) CY1107859T1 (da)
DE (1) DE60317070T2 (da)
DK (1) DK1529216T3 (da)
ES (1) ES2297248T3 (da)
IL (1) IL166539A (da)
MX (1) MXPA05001270A (da)
NO (1) NO20051024L (da)
NZ (1) NZ585114A (da)
PL (1) PL210512B1 (da)
PT (1) PT1529216E (da)
WO (1) WO2004015420A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1692519B1 (en) 2003-12-03 2010-06-02 Glycominds Ltd. Method for diagnosing diseases based on levels of anti-glycan antibodies
JP2008504531A (ja) * 2004-06-24 2008-02-14 ザ スクリップス リサーチ インスティテュート 切断可能なリンカーを有するアレイ
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
EP2517727A3 (en) * 2005-09-29 2013-10-30 Caprion Proteomics USA, LLC Biomarkers for multiple sclerosis and methods of use thereof
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
KR20160132034A (ko) 2014-03-13 2016-11-16 우니페르시테트 바젤 미엘린-관련 당단백질에 대한 IgM 항체와 결합하는 탄수화물 리간드
WO2016026143A1 (en) * 2014-08-22 2016-02-25 Huiru Wang Saccharide-based biomarkers and therapeutics
WO2016123565A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of ms disease course
US11091591B2 (en) 2015-09-16 2021-08-17 Universität Basel Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids
AU2017286979B2 (en) 2016-07-01 2023-04-27 Dignity Health Diagnostic or predictor of relapsing remitting multiple sclerosis
WO2019195448A1 (en) * 2018-04-03 2019-10-10 Creatics Llc Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
JPH02161357A (ja) * 1988-12-15 1990-06-21 Tosoh Corp 免疫測定用材料の安定化方法
NZ513533A (en) * 1999-02-17 2003-11-28 Glycominds Ltd Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
CN1406153A (zh) * 2000-01-10 2003-03-26 基因谱公司 线性探针载体
AU2001288431A1 (en) 2000-08-28 2002-03-13 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
AU2003263409B2 (en) * 2002-08-02 2010-05-27 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
US20040077023A1 (en) 2004-04-22
CA2494422A1 (en) 2004-02-19
WO2004015420A8 (en) 2004-09-10
NZ585114A (en) 2011-09-30
ATE376672T1 (de) 2007-11-15
US7537900B2 (en) 2009-05-26
IL166539A0 (en) 2006-01-15
WO2004015420B1 (en) 2004-04-29
AU2003263409B2 (en) 2010-05-27
EP1529216A1 (en) 2005-05-11
JP4721703B2 (ja) 2011-07-13
ES2297248T3 (es) 2008-05-01
JP2006501441A (ja) 2006-01-12
EP1529216B1 (en) 2007-10-24
JP2009258138A (ja) 2009-11-05
US20100081160A1 (en) 2010-04-01
IL166539A (en) 2010-11-30
CY1107859T1 (el) 2013-06-19
AU2003263409A1 (en) 2004-02-25
MXPA05001270A (es) 2005-08-03
DE60317070D1 (de) 2007-12-06
DE60317070T2 (de) 2008-07-24
NO20051024L (no) 2005-05-02
BR0313194A (pt) 2005-07-12
WO2004015420A1 (en) 2004-02-19
PT1529216E (pt) 2008-01-30
PL374869A1 (en) 2005-11-14
PL210512B1 (pl) 2012-01-31

Similar Documents

Publication Publication Date Title
NO20051024L (no) Fremgangsmate for diagnostisering av multippel sklerose
DE60228557D1 (de) Candida-nachweis
DK1718196T3 (da) Metabolisk overvågning, fremgangsmåde og apparat til indikation af en sundhedsrelateret tilstand hos et individ
NO20064239L (no) Anti-AB-antistoff
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
DE60331345D1 (de) Probensubstrat zur biologischen untersuchung
WO2004044798A3 (en) Global analysis of software objects generated from a hardware description
DE602005020446D1 (de) Konfokale flüssigkeitsstandmessung
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
DE602005024254D1 (da)
TW200801506A (en) Method and device of identifying individuals
DK1549208T3 (da) Fremgangmåde til omdannelse af venøse blodværdier til arterielle blodværdier, system til anvendelse af fremgangsmåden
ATE365324T1 (de) Nachweis durch serrs in mikrofluidischer umgebung
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
DK1421377T3 (da) Naturlig ligand for den orphane G-proteinkoblede receptor GPR86 og metoder til anvendelse
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
DE602004011505D1 (de) Verfahren zur chromatographischen analyse einer proteinlösung
DK1495056T3 (da) Fremgangsmåde til analyse af antistofdisulfidisomere
DK1192443T3 (da) Fremgangsmåde til kvantificering af endotel-mikrosfærer
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests
DE60231845D1 (de) Diagnoseverfahren für proteinprofilierung
DE50309626D1 (de) Verfahren zur vorhersage der expressionseffizienz in zellfreien expressionssystemen
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
BG105829A (en) Method for periodic control and assessment of the strength of the concrete